Skip to main content
HairCited

الوخز بالإبر الدقيقة لـ الثعلبة الأندروجينية

A

بناءً على 52 دراسة (5 meta-analyses, 11 RCTs) بمشاركة 8,451 مشاركًا إجمالاً. 44/52 دراسة تُظهر تأثيرات إيجابية.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'ingredient\u003Dmicroneedling\u0026condition\u003Dandrogenetic\u002Dalopecia'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

الخلاصة

Microneedling has strong, well-established evidence for androgenetic alopecia, particularly when combined with topical minoxidil, and is one of the best-supported adjunct therapies for pattern hair loss.

  • 44 out of 52 studies show positive effects, supported by 5 meta-analyses and 11 RCTs
  • Most effective when combined with topical minoxidil, significantly boosting its effectiveness
  • Stimulates growth factors and wound-healing pathways that support hair follicle regeneration
  • Both professional and at-home microneedling approaches have demonstrated benefits

Key Study Findings

non-randomized controlled trial n=60 16 weeks Open-label
Clinical Efficacy and Mechanisms of Microneedling Alone or Combined With Drugs in the Treatment of …
Dose: Mild group: microneedling alone (8 weeks); Moderate group: microneedling + 5% minoxidil (12 weeks); مقابل: Placebo التأثير: All groups showed significant decrease in HLSS and increase in hair density post-treatment (p<0.001) p<0.001
Controlled Clinical Trial n=8 12 weeks Single-blind
Dutasteride Infusion in Male Androgenetic Alopecia Using a Novel Drug Delivery Technique: MMP®.
Dose: 3 sessions of dutasteride microinfusion (monthly) مقابل: Saline solution placebo via MMP Outcome: Clinical assessment and patient self-assessment التأثير: None None

المجتمع المدروس: Adult males with androgenetic alopecia

Review
Microneedling Combined With Drugs and Stem Cells for Treating Androgenetic Alopecia.
Dose: None مقابل: None Outcome: None التأثير: None None

المجتمع المدروس: None

review
The role of microtrauma in hair regrowth and regeneration in non-scarring alopecia.
Dose: Various microtrauma procedures: microneedling, fractional/non-fractional lasers, contact immunothera مقابل: Placebo التأثير: Positive outcomes reported for hair density and thickness with microneedling, lasers, LLLT, and PRP None
scoping_review n=16
A Scoping Review of Exosome Delivery Applications in Hair Loss.
Dose: variable; exosomes predominantly from mesenchymal stem cells (MSCs) مقابل: Placebo التأثير: None None

Key Statistics

62

الدراسات

8574

المشاركون

Positive

A

التقييم

Referenced Papers

Aesthetic plastic surgery 2025 14 اقتباسات
Journal of cutaneous … 2025 2 اقتباسات
Dermatology (Basel, Switzerland) 2024 14 اقتباسات
Journal of cosmetic … 2024 11 اقتباسات
Journal of clinical … 2024 10 اقتباسات
Journal of cosmetic … 2024 8 اقتباسات
Journal of cutaneous … 2024 3 اقتباسات
Clinical, cosmetic and … 2023 58 اقتباسات
Skin appendage disorders 2023 4 اقتباسات
Asian journal of … 2023 2 اقتباسات
Faculty reviews 2022 44 اقتباسات
Dermatology and therapy 2022 43 اقتباسات
Journal of cosmetic … 2022 35 اقتباسات
Dermatologic surgery : … 2022 15 اقتباسات
Journal of cosmetic … 2022 9 اقتباسات
Dermatologic surgery : … 2021 58 اقتباسات
Dermatologic therapy 2020 48 اقتباسات
Journal of plastic, … 2018 137 اقتباسات
Journal of the … 2018 114 اقتباسات

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

الجرعات الشائعة

hairloss:
1.5 mm depth, weekly sessions

الحد الأعلى: Not applicable

الجرعات المدروسة في الأبحاث

الجرعة المدة التأثير ن
Mild group: microneedling alone (8 weeks); Moderate group: microneedling + 5% minoxidil (12 weeks); 16 weeks Positive 60
3 sessions of dutasteride microinfusion (monthly) 12 weeks Positive 8
None -- Mixed --
Various microtrauma procedures: microneedling, fractional/non-fractional lasers, contact immunothera -- Positive --
None -- Mixed --
variable; exosomes predominantly from mesenchymal stem cells (MSCs) -- Positive 16
None -- Positive 631
None -- Mixed --

أفضل وقت للتناول: Weekly sessions; avoid minoxidil for 24 hours post-treatment

Safety & Side Effects

الآثار الجانبية المُبلّغ عنها

  • Scalp redness and inflammation (24-72 hours)
  • Mild bleeding at treatment site
  • Scalp tenderness and soreness
  • Rare: infection if proper sterilization not maintained

التفاعلات المعروفة

  • Topical minoxidil (enhanced absorption; wait 24 hours after microneedling to apply)
  • Blood thinners (may increase bleeding during procedure)
  • Topical retinoids (discontinue 3-5 days before treatment)

الحد الأقصى المسموح به: Not applicable

استشر مقدم الرعاية الصحية دائماً قبل البدء بأي مكمل غذائي.

Frequently Asked Questions

Does الوخز بالإبر الدقيقة help with الثعلبة الأندروجينية?
Based on 62 studies with 8,574 participants, there is strong evidence from multiple clinical trials that الوخز بالإبر الدقيقة may support الثعلبة الأندروجينية management. Our evidence grade is A (Strong Evidence).
How much الوخز بالإبر الدقيقة should I take for الثعلبة الأندروجينية?
Studies have used various dosages. A commonly studied range is 1.5 mm depth, weekly sessions. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of الوخز بالإبر الدقيقة?
Reported side effects may include Scalp redness and inflammation (24-72 hours), Mild bleeding at treatment site, Scalp tenderness and soreness, Rare: infection if proper sterilization not maintained. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for الوخز بالإبر الدقيقة and الثعلبة الأندروجينية?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 62 peer-reviewed studies with 8,574 total participants. The overall direction of effect is positive.

Related Evidence

إخلاء مسؤولية FDA: لم تُقيَّم هذه البيانات من قبل إدارة الغذاء والدواء (FDA). لا تهدف المنتجات والمعلومات الواردة في هذا الموقع إلى تشخيص أو علاج أو شفاء أو الوقاية من أي مرض. تستند تقييمات الأدلة المعروضة إلى تحليلنا للأبحاث المحكّمة المنشورة ولا تُشكّل نصيحة طبية. استشر مقدم الرعاية الصحية دائماً قبل البدء بأي نظام مكملات.